As a prophylactic and drug for improving metabolic processes and the general condition of people of working and old age, including premature aging, asthenic syndrome, as well as during convalescence after infectious diseases, in the postoperative period, after prolonged therapy with broad-spectrum antibiotics.
Composition and form of release
Undevit is made in the form of dragees. The preparation contains retinol palmitate, thiamine hydrochloride, riboflavin, ascorbic acid, tocopherol acetate, pyridoxine hydrochloride, calcium pantothenate, nicotinamide, rutoside, folic acid, cyanocobalamin.
Undevit is prescribed to improve the general condition and metabolism in middle-aged and elderly patients. The drug is taken after undergoing a course of antibacterial therapy. It is used in the treatment and prevention of hypovitaminosis, as well as in the recovery period after severe illnesses.
Undevit is not prescribed to patients with hypersensitivity to the components of the drug, with ulcerative lesions of the stomach and intestines in the active phase, nephrolithiasis, severe renal impairment, chronic glomerulonephritis, hyperuricemia, gout, erythrocytosis, thrombophleatcois , neoplasms, arterial hypertension, hypervitaminosis of groups E and A, glucose-galactose malabsorption syndrome, fructose intolerance and severe liver diseases.
The preparation contains sugar, which must be taken into account when prescribing it to patients with diabetes mellitus.
Undevit can be used only as part of monotherapy, since when taken together with other vitamin complexes, the patient is highly likely to develop an overdose.
Application during pregnancy and lactation
Undevit is used with caution in the treatment of nursing and pregnant women, and only with a careful balance of benefits and harms from its use. In the therapy of pregnant women, to reduce the risk of a teratogenic effect, the drug is recommended to be taken one tablet per day.
Method of administration and dosage
Undevit should be taken after meals to reduce the negative effects of the drug on the gastric mucosa. In order to prevent hypovitaminosis, the drug is recommended to be taken 1 tablet once a beat.
During intense physical exertion, illness, after surgery, and elderly patients, it is recommended to take the drug from 2 to 3 tablets once a day. The duration of treatment can vary from 20 to 30 days. A repetition of the course of treatment is possible only one or three months after the last dose of the drug.
When taking Undevit, urine staining is possible in bright yellow color. This symptom is absolutely safe, has no clinical significance and is caused by the presence of riboflavin in the preparation.
An overdose of Undevit is characterized by the development of dyspeptic disorders, allergic reactions, liver dysfunction, headaches, lethargy, drowsiness, irritability, facial flushing.
With the development of symptoms of Undevit intoxication, it is recommended to stop taking it immediately and prescribe the patient to receive enterosorbents and symptomatic treatment.
When taking Undevit, patients may experience epigastric pain, dizziness, dyspeptic disorders, heartburn, sleep disturbances, arterial hypertension, convulsions, arrhythmia, hair loss, liver dysfunction and allergic reactions.
Storage conditions and periods
It is recommended to store Undevit in a dry and protected from light, and also out of the reach of children. Dragee shelf life is 1 year.